Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNet

Global TravEpiNet Consortium

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Few data regarding the use of Japanese encephalitis (JE) vaccine in clinical practice are available. We identified 711 travelers at higher risk and 7,578 travelers at lower risk for JE who were seen at US Global TravEpiNet sites from September of 2009 to August of 2012. Higher-risk travelers were younger than lower-risk travelers (median age = 29 years versus 40 years, P < 0.001). Over 70% of higher-risk travelers neither received JE vaccine during the clinic visit nor had been previously vaccinated. In the majority of these instances, clinicians determined that the JE vaccine was not indicated for the higher-risk traveler, which contradicts current recommendations of the Advisory Committee on Immunization Practices. Better understanding is needed of the clinical decision-making regarding JE vaccine in US travel medicine practices.

Original languageEnglish (US)
Pages (from-to)694-698
Number of pages5
JournalAmerican Journal of Tropical Medicine and Hygiene
Volume91
Issue number4
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Japanese Encephalitis Vaccines
Travel Medicine
Japanese Encephalitis
Advisory Committees
Ambulatory Care
Immunization

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases
  • Virology

Cite this

Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNet. / Global TravEpiNet Consortium.

In: American Journal of Tropical Medicine and Hygiene, Vol. 91, No. 4, 01.01.2014, p. 694-698.

Research output: Contribution to journalArticle

@article{d4d9befd2987433d98c9417359106556,
title = "Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNet",
abstract = "Few data regarding the use of Japanese encephalitis (JE) vaccine in clinical practice are available. We identified 711 travelers at higher risk and 7,578 travelers at lower risk for JE who were seen at US Global TravEpiNet sites from September of 2009 to August of 2012. Higher-risk travelers were younger than lower-risk travelers (median age = 29 years versus 40 years, P < 0.001). Over 70{\%} of higher-risk travelers neither received JE vaccine during the clinic visit nor had been previously vaccinated. In the majority of these instances, clinicians determined that the JE vaccine was not indicated for the higher-risk traveler, which contradicts current recommendations of the Advisory Committee on Immunization Practices. Better understanding is needed of the clinical decision-making regarding JE vaccine in US travel medicine practices.",
author = "{Global TravEpiNet Consortium} and Deshpande, {Bhushan R.} and Rao, {Sowmya R.} and Jentes, {Emily S.} and Hills, {Susan L.} and Marc Fischer and Gershman, {Mark D.} and Brunette, {Gary W.} and Ryan, {Edward T.} and LaRocque, {Regina C.} and Abraham, {George M.} and Salvador Alvarez and Vernon Ansdell and Yates, {Johnnie A.} and Atkins, {Elisha H.} and John Cahill and Birich, {Holly K.} and Dagmar Vitek and Connor, {Bradley A.} and Roberta Dismukes and Jessica Fairley and Phyllis Kozarsky and Ronke Dosunmu and Goad, {Jeffrey A.} and Edith Mirzaian and Brian Kendall and Hale, {De Von} and Hynes, {Noreen A.} and Frederique Jacquerioz and Susan McLellan and Mark Knouse and Jennifer Lee and Alawode Oladele and Hanna Demeke and Roger Pasinski and Wheeler, {Amy E.} and Jessica Rosen and Cabellon, {Noreen N.} and Schwartz, {Brian S.} and William Stauffer and Patricia Walker and Joseph Vinetz",
year = "2014",
month = "1",
day = "1",
doi = "10.4269/ajtmh.14-0062",
language = "English (US)",
volume = "91",
pages = "694--698",
journal = "American Journal of Tropical Medicine and Hygiene",
issn = "0002-9637",
publisher = "American Society of Tropical Medicine and Hygiene",
number = "4",

}

TY - JOUR

T1 - Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNet

AU - Global TravEpiNet Consortium

AU - Deshpande, Bhushan R.

AU - Rao, Sowmya R.

AU - Jentes, Emily S.

AU - Hills, Susan L.

AU - Fischer, Marc

AU - Gershman, Mark D.

AU - Brunette, Gary W.

AU - Ryan, Edward T.

AU - LaRocque, Regina C.

AU - Abraham, George M.

AU - Alvarez, Salvador

AU - Ansdell, Vernon

AU - Yates, Johnnie A.

AU - Atkins, Elisha H.

AU - Cahill, John

AU - Birich, Holly K.

AU - Vitek, Dagmar

AU - Connor, Bradley A.

AU - Dismukes, Roberta

AU - Fairley, Jessica

AU - Kozarsky, Phyllis

AU - Dosunmu, Ronke

AU - Goad, Jeffrey A.

AU - Mirzaian, Edith

AU - Kendall, Brian

AU - Hale, De Von

AU - Hynes, Noreen A.

AU - Jacquerioz, Frederique

AU - McLellan, Susan

AU - Knouse, Mark

AU - Lee, Jennifer

AU - Oladele, Alawode

AU - Demeke, Hanna

AU - Pasinski, Roger

AU - Wheeler, Amy E.

AU - Rosen, Jessica

AU - Cabellon, Noreen N.

AU - Schwartz, Brian S.

AU - Stauffer, William

AU - Walker, Patricia

AU - Vinetz, Joseph

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Few data regarding the use of Japanese encephalitis (JE) vaccine in clinical practice are available. We identified 711 travelers at higher risk and 7,578 travelers at lower risk for JE who were seen at US Global TravEpiNet sites from September of 2009 to August of 2012. Higher-risk travelers were younger than lower-risk travelers (median age = 29 years versus 40 years, P < 0.001). Over 70% of higher-risk travelers neither received JE vaccine during the clinic visit nor had been previously vaccinated. In the majority of these instances, clinicians determined that the JE vaccine was not indicated for the higher-risk traveler, which contradicts current recommendations of the Advisory Committee on Immunization Practices. Better understanding is needed of the clinical decision-making regarding JE vaccine in US travel medicine practices.

AB - Few data regarding the use of Japanese encephalitis (JE) vaccine in clinical practice are available. We identified 711 travelers at higher risk and 7,578 travelers at lower risk for JE who were seen at US Global TravEpiNet sites from September of 2009 to August of 2012. Higher-risk travelers were younger than lower-risk travelers (median age = 29 years versus 40 years, P < 0.001). Over 70% of higher-risk travelers neither received JE vaccine during the clinic visit nor had been previously vaccinated. In the majority of these instances, clinicians determined that the JE vaccine was not indicated for the higher-risk traveler, which contradicts current recommendations of the Advisory Committee on Immunization Practices. Better understanding is needed of the clinical decision-making regarding JE vaccine in US travel medicine practices.

UR - http://www.scopus.com/inward/record.url?scp=84907705156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907705156&partnerID=8YFLogxK

U2 - 10.4269/ajtmh.14-0062

DO - 10.4269/ajtmh.14-0062

M3 - Article

C2 - 25070999

AN - SCOPUS:84907705156

VL - 91

SP - 694

EP - 698

JO - American Journal of Tropical Medicine and Hygiene

JF - American Journal of Tropical Medicine and Hygiene

SN - 0002-9637

IS - 4

ER -